Published in Horm Res on January 21, 2009
The dog as an animal model for DISH? Eur Spine J (2010) 0.93
Renal function and morphology in aged Beagle dogs before and after hydrocortisone administration. PLoS One (2012) 0.79
Animal models of adrenocortical tumorigenesis. Mol Cell Endocrinol (2011) 0.78
Alteration of somatostatin receptor 2 expression in canine mammary gland tumor. J Vet Med Sci (2015) 0.77
Lack of Ubiquitin Specific Protease 8 (USP8) Mutations in Canine Corticotroph Pituitary Adenomas. PLoS One (2016) 0.75
[Cushing's syndrome. I. New diagnostic developments]. Ned Tijdschr Geneeskd (2006) 2.73
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2008) 2.70
Octreotide. N Engl J Med (1996) 2.67
The peptide components of bee venom. Eur J Biochem (1976) 2.34
Field study of the prevalence of lameness in horses with back problems. Vet Rec (2004) 2.11
Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion. Am J Med (1994) 1.93
Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease. Br J Surg (2009) 1.76
Phosphatidylinositol 3-kinase, not extracellular signal-regulated kinase, regulates activation of the antioxidant-responsive element in IMR-32 human neuroblastoma cells. J Biol Chem (2001) 1.74
Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy. J Clin Endocrinol Metab (1990) 1.71
[Cushing's syndrome. II. New forms of treatment]. Ned Tijdschr Geneeskd (2006) 1.47
Effects of corticotrophin-releasing hormone, vasopressin and insulin-like growth factor-I on proliferation of and adrenocorticotrophic hormone secretion by canine corticotrophic adenoma cells in vitro. Eur J Endocrinol (1998) 1.41
[Prolactinoma; diagnosis and treatment]. Ned Tijdschr Geneeskd (1996) 1.37
Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours. Endocr Relat Cancer (2003) 1.32
Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J Clin Endocrinol Metab (2004) 1.28
Indoor confinement and physical inactivity rather than the proportion of dry food are risk factors in the development of feline type 2 diabetes mellitus. Vet J (2007) 1.24
Nrf2-dependent activation of the antioxidant responsive element by tert-butylhydroquinone is independent of oxidative stress in IMR-32 human neuroblastoma cells. Biochem Biophys Res Commun (2001) 1.24
Letter: An anti-inflammatory peptide from bee venom. Nature (1973) 1.23
Quality of life in patients after long-term biochemical cure of Cushing's disease. J Clin Endocrinol Metab (2005) 1.22
[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation. Life Sci (1991) 1.20
Salivary cortisol is related to atherosclerosis of carotid arteries. J Clin Endocrinol Metab (2008) 1.18
Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol (2003) 1.17
Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire. Eur J Endocrinol (2008) 1.14
Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy. Cancer Res (1998) 1.13
Cross-sectional study of the prevalence and clinical features of osteoarthritis in 100 cats. Vet J (2010) 1.11
Large body size in the dog is associated with transient GH excess at a young age. J Endocrinol (2001) 1.11
The late reaction following bronchial provocation with house dust mite allergen. Dependence on arachidonic acid metabolism. Clin Exp Immunol (1983) 1.10
Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathways. Curr Cancer Drug Targets (2009) 1.10
Neuroendocrine tumor markers. Front Neuroendocrinol (2001) 1.08
Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in rats. J Nucl Med (1995) 1.08
Diagnosis of spontaneous canine hyperadrenocorticism: 2012 ACVIM consensus statement (small animal). J Vet Intern Med (2013) 1.08
Posturographic evidence of nonorganic sway patterns in normal subjects, patients, and suspected malingerers. Otolaryngol Head Neck Surg (1997) 1.07
Chromosomal instability predicts metastatic disease in patients with insulinomas. Endocr Relat Cancer (2005) 1.02
Drains for thyroidectomy/parathyroidectomy: fact or fiction? Ann R Coll Surg Engl (1999) 1.02
Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes. Br J Ophthalmol (2004) 1.02
Fluconazole inhibits human adrenocortical steroidogenesis in vitro. J Endocrinol (2012) 1.00
Somatostatin and somatostatin receptors in the immune system: a review. Eur Cytokine Netw (2000) 1.00
Low circulating insulin-like growth factor I bioactivity in elderly men is associated with increased mortality. J Clin Endocrinol Metab (2008) 0.99
Anti-inflammatory property of 401 (MCD-peptide), a peptide from the venom of the bee Apis mellifera (L.). Br J Pharmacol (1974) 0.99
Cerebrospinal fluid leakage during transsphenoidal surgery: postoperative external lumbar drainage reduces the risk for meningitis. Pituitary (2004) 0.98
Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment. Clin Endocrinol (Oxf) (2013) 0.97
Effect of inflammatory cytokines and growth factors on tumour cell adhesion to the peritoneum. J Pathol (2001) 0.97
Neuroendocrine tumors and somatostatin: imaging techniques. J Endocrinol Invest (2005) 0.96
Evaluation in vitro and in rats of 161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy. Eur J Nucl Med (1995) 0.94
Insulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir. Growth Horm IGF Res (2010) 0.94
A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height. Clin Endocrinol (Oxf) (2004) 0.93
Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway. Am J Physiol Endocrinol Metab (2007) 0.93
Long-term treatment with the dopamine agonist quinagolide of patients with clinically non-functioning pituitary adenoma. Eur J Endocrinol (2000) 0.93
The dog as an animal model for DISH? Eur Spine J (2010) 0.93
Thyroid aspiration cytology in Newcastle: a six year cytology/histology correlation study. Ann R Coll Surg Engl (2000) 0.92
Review and retrospective analysis of degenerative lumbosacral stenosis in 156 dogs treated by dorsal laminectomy. Vet Comp Orthop Traumatol (2008) 0.91
Octreotide and related somatostatin analogs in the diagnosis and treatment of pituitary disease and somatostatin receptor scintigraphy. Front Neuroendocrinol (1993) 0.91
Intervertebral disc disease in dogs - part 1: a new histological grading scheme for classification of intervertebral disc degeneration in dogs. Vet J (2012) 0.91
Ethnic differences in outcomes of diabetes care and the role of self-management behavior. Patient Educ Couns (2008) 0.91
Effects of somatostatin analogs on a growth hormone-releasing hormone secreting bronchial carcinoid, in vivo and in vitro studies. J Clin Endocrinol Metab (2008) 0.91
Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects. J Endocrinol Invest (2005) 0.91
Circulating free insulin-like growth factor (IGF)-I, total IGF-I, and IGF binding protein-3 levels do not predict the future risk to develop prostate cancer: results of a case-control study involving 201 patients within a population-based screening with a 4-year interval. J Clin Endocrinol Metab (2004) 0.90
Somatostatin receptor-dependent growth inhibition of liver metastases by octreotide. Br J Surg (1994) 0.90
Diagnosis and treatment of acromegaly complications. J Endocrinol Invest (2003) 0.90
Comparison of two suture materials for intradermal skin closure in dogs. Vet Q (1997) 0.90
Plasma aldosterone concentrations and plasma renin activity in healthy dogs and dogs with hyperadrenocorticism. Vet Rec (2003) 0.90
Long-term efficacy and safety of pegvisomant in combination with long-acting somatostatin analogs in acromegaly. J Clin Endocrinol Metab (2014) 0.89
Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation. Head Neck (1999) 0.89
Inflammatory cytokines stimulate the adhesion of colon carcinoma cells to mesothelial monolayers. Dig Dis Sci (2007) 0.89
Diagnosis and treatment of hypopituitarism: an update. Pituitary (2005) 0.89
The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy. J Clin Endocrinol Metab (2012) 0.89
Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome. Rev Endocr Metab Disord (2008) 0.88
Growth hormone excess and the effect of octreotide in cats with diabetes mellitus. Domest Anim Endocrinol (2008) 0.88
Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly. Diabetologia (2012) 0.88
Blockade of the growth hormone (GH) receptor unmasks rapid GH-releasing peptide-6-mediated tissue-specific insulin resistance. J Clin Endocrinol Metab (2001) 0.88
Leucocyte chemotactic activity in the parallel bioassay of guinea--pig lymphokines. Immunology (1977) 0.87
The role of IGF-I in the development of cardiovascular disease in type 2 diabetes mellitus: is prevention possible? Eur J Endocrinol (2002) 0.87
Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy. Eur J Endocrinol (2001) 0.87
The value of plasma markers for the clinical behaviour of phaeochromocytomas. Eur J Endocrinol (2002) 0.87
The structures of some peptides from bee venom. Eur J Biochem (1978) 0.87
Pituitary function and morphology in two German shepherd dogs with congenital dwarfism. Vet Rec (1999) 0.87
New somatostatin analogs: will they fulfil old promises? Eur J Endocrinol (2002) 0.87
Insulin sensitivity and beta-cell function in healthy cats: assessment with the use of the hyperglycemic glucose clamp. Horm Metab Res (2007) 0.86
Pre-clinical evaluation of [(111)In-DTPA-Pro(1), Tyr(4)]bombesin, a new radioligand for bombesin-receptor scintigraphy. Int J Cancer (1999) 0.86
Igf-I and longevity. Horm Res (2004) 0.86
Persistent Mullerian duct syndrome in a Miniature Schnauzer dog with signs of feminization and a Sertoli cell tumour. Reprod Domest Anim (2008) 0.86
The prevention of peridural adhesions. A comparative long-term histomorphometric study using a biodegradable barrier and a fat graft. J Bone Joint Surg Br (1998) 0.85
Influence of litter size and breed on the duration of gestation in dogs. J Reprod Fertil Suppl (2001) 0.85
Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy. Int J Cancer (1999) 0.85
Whole body positron emission tomography imaging of activated lymphoid tissues during acute simian-human immunodeficiency virus 89.6PD infection in rhesus macaques. Virology (2000) 0.85
Best practice for the pharmacological management of hyperthyroid cats with antithyroid drugs. J Small Anim Pract (2013) 0.85
Spinal hyperostosis in humans and companion animals. Vet Q (2013) 0.84
New developments in the medical treatment of Cushing's syndrome. Endocr Relat Cancer (2012) 0.84
Termination of mid-gestation pregnancy in bitches with aglepristone, a progesterone receptor antagonist. Theriogenology (2000) 0.84
Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro. J Mol Endocrinol (2008) 0.84
Somatostatin receptor distribution and function in immune system. Dig Liver Dis (2004) 0.84